Showing results (261-270 of 296) with videos related to

Sort By:
Pageof 30
BMC Research Notes|January 28, 2012
Evaluation of prognostic factors and the role of chemotherapy in unfavorable carcinoma of unknown primary site: a 10-year cohort studyKuo-Wei Chen, Chia-Jen Liu, Hsueh-Ju Lu, et al.
BMC Cancer|March 3, 2026
Circulating tumor cells (CTCs) enumeration and machine-learning based diagnostic biomarkers for breast cancer detectionChun-Yu Liu, Yu-Hsiang Lin, Yi-Fang Tsai, et al.
Annals of Hematology|May 18, 2011
International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agentsSheng-Hsiang Yang, Hao-Wei Teng, Ying-Chung Hong, et al.
Journal of the Chinese Medical Association : JCMA|September 25, 2021
Clinical outcomes and metastatic behavior between de novo versus recurrent HER2-positive metastatic breast cancer: A 17-year single-institution cohort study at Taipei Veterans General HospitalHan-Fang Cheng, Yi-Fang Tsai, Chi-Cheng Huang, et al.
Annals of Hematology|May 29, 2013
Diminishing prognostic role of preexisting diabetes mellitus for patients with diffuse large B-cell lymphoma in the rituximab eraHsueh-Ju Lu, Yu-Chung Huang, Chun-Yu Liu, et al.
Neuro-Oncology Advances|May 15, 2026
Boron neutron capture therapy plus bevacizumab versus bevacizumab alone in recurrent glioblastoma: A propensity score-matched analysisShuo-Fu Chen, Yi-Yen Lee, Chun-Yu Liu, et al.
Ebiomedicine|April 9, 2020
Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progressionTzu-Ting Huang, Ling-Ming Tseng, Ji-Lin Chen, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|February 23, 2023
Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma PatientsTe-Lin Hsu, Chun-Kuang Tsai, Chun-Yu Liu, et al.
Annals of Hematology|June 8, 2011
Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphomaYu-Chung Huang, Chia-Jen Liu, Chun-Yu Liu, et al.
Thrombosis and Haemostasis|April 27, 2012
A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring systemYuan-Bin Yu, Jyh-Pyng Gau, Chun-Yu Liu, et al.
Pageof 30